• SENSEX 80,346.38
    58.00 (+0.07%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Cochin Shipyard
    1,600.40 1,169.00(%)
  • Torrent Pharma.
    3,360.00 3,589.95(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Tata Motors
    642.00 542.55(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Samvardh. Mothe.
    132.05 107.30(%)
  • Data Pattern
    2,459.05 1,350.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • IndusInd Bank
    810.40 605.40(%)
  • Trent
    5,134.00 4,058.45(%)
  • Bharat Electron
    312.50 221.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • ICICI Bank
    1,424.00 1,051.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Sonata Software
    415.25 762.00(%)
  • HDFC Bank
    1,936.40 1,977.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jagsonpal Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2171.0
  • ISIN : INE048B01035
227.46 -5 (-2.25%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    226.95

  • Today’s High

    235.37

  • Open

    233.88

  • Perv Close

    232.70

  • 52W Low

    110.00

  • 52W High

    328.04

Key Indicators

  • P/E(TTM)

    41.40

  • Mar.Cap (₹Cr.)

    1,510.04

  • Div & Yield %

    0.88

  • Book Value(₹)

    29.70

  • Debt-Equity Ratio

    -2.25

  • AGM Date

    29-Apr-2025

  • EPS

    5.49

  • P/E Ratio

    41.40

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,510.04

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.28

  • BV (₹)

    29.70

  • Sales( ₹ in Cr.)

    208.70

  • NP (in Cr.)

    22.46

  • NP Var(%)

    -21.0

  • Div%

    100.0

  • CPS (₹)

    3.60

  • EPS (₹)

    3.40

  • Traded Value (₹ in Lakhs)

    1,508.98

  • 52 Week High

    328.04

  • 52 Week Low

    110.00

  • Price BSE

    227.0

  • Price NSE

    227.00

  • Market Capital( in Cr.)

    1,508.98

  • P/C Ratio

    62.50

  • P/E Ratio

    67.10

  • Price Vs.BV

    3.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 208.70 236.71 217.58 187.95 158.57 166.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 208.70 236.71 217.58 187.95 158.57 166.83
Other Income 9.28 5.73 3.43 4.39 2.53 1.43
Stock Adjustments -3.90 -4.30 -5.61 -5.28 -1.25 -19.42
Total Income 214.08 238.14 215.40 187.06 159.85 148.84
EXPENDITURE :            
Raw Materials 76.08 88.04 83.35 75.50 54.94 53.43
Power and Fuel Cost 0.17 0.29 0.47 0.52 0.64 1.41
Employee Cost 61.80 65.18 57.68 53.98 50.37 46.61
Other Manufacturing Expenses 0.73 0.52 0.91 0.48 0.45 0.73
Selling and Administration Expenses 41.09 41.66 42.50 31.88 38.34 32.23
Miscellaneous Expenses 1.87 6.03 2.05 1.22 4.04 3.66
Employee Benefit Expenses 61.80 65.18 57.68 53.98 50.37 46.61
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 181.74 201.72 186.95 163.59 148.79 138.07
Operating Profit 32.34 36.42 28.46 23.47 11.05 10.77
Interest 0.81 0.41 0.29 0.51 0.51 0.75
Gross Profit 31.53 36.01 28.17 22.96 10.54 10.02
Depreciation 1.66 1.21 1.53 1.09 1.13 1.02
Profit Before Tax 29.87 34.80 26.64 21.87 9.41 9.00
Current Tax 7.56 7.63 7.40 6.05 1.57 1.85
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.15 0.46 0.38 -1.23 -0.03 -0.07
Reported Net Profit 22.46 26.72 18.86 17.06 7.87 7.22
Extraordinary Items 0.00 -1.89 0.50 0.00 -0.02 0.00
Adjusted Net Profit 22.46 28.61 18.36 17.06 7.89 7.22
Adjustment below Net Profit 0.29 -1.56 3.95 -3.54 0.00 0.00
P & L Balance brought forward 94.54 69.37 58.59 47.69 41.13 34.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.10 0.00 12.02 2.62 1.31 0.79
P & L Balance carried down 104.19 94.54 69.37 58.59 47.69 41.13
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 100.00 80.00 20.00 10.00 5.00
Dividend Per Share(Rs) 5.00 5.00 4.00 1.00 0.50 0.25
Earnings Per Share-Unit Curr 8.50 10.20 7.20 6.51 3.00 2.75
Earnings Per Share(Adj)-Unit Curr 3.40 4.08 2.88 2.60 1.20 1.10
Book Value 70.88 60.65 50.68 43.55 39.39 36.89
Book Value(Adj)-Unit Curr 28.35 24.26 20.27 17.42 15.76 14.76

Shareholding Pattern

  • Promoter Group

    67.78%

  • Public Share Holding

    32.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 22,920,800 34.52 22,920,800 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 5,717,950 5,717,950.00 5,717,950 5,717,950
Sub Total 28,638,750 43.13 28,638,750 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 13,335,635 20.08 13,335,635 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,030,400 4.56 3,030,400 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,366,035 24.65 16,366,035 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,000 0.00 1,500 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,396,798 2.10 1,396,798 11
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,398,798 2.11 1,398,298 13
2] Non Institution
Bodies Corporate 1,746,195 2.63 1,743,995 114
Clearing Members 27,631 0.04 27,631 22
Directors of their Relatives 269,675 0.41 269,675 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 387,868 0.58 387,868 294
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 790,866 1.19 790,866 355
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,800,739 5.72 3,800,739 6
Individuals holding nominal share capital up to Rs. 1 lakh 10,106,274 15.22 9,615,470 20,271
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,000 0.01 5,000 1
Others 2,860,799 4.31 2,860,799 3
Sub Total 19,995,047 30.11 19,502,043 21,067
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 66,398,630 100.00 65,905,126 21,085

Company Background

Jagsonpal Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Jagsonpal Pharmaceuticals Ltd
  • BSE Code : 2171.0
  • ISIN : INE048B01035

  • Incorporation Year

    1978

  • Registered Office

    T-210 J
    Shahpur Jat, New Delhi,
    New Delhi-110049

  • Telephone

    91-011-46181100/46109900

  • FAX

    91-011-26498341

  • Chairman

    Harsha Raghavan

  • Managing Director

    Manish Gupta

  • Company Secretary

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MCS Ltd
    F-65 1st Floor,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Jagsonpal Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jagsonpal Pharma 227.30 217.98 208.70 28.85 16.89
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92